Assessment of factor v leiden, prothrombin gene mutation and methylenetetrahydrofolate reductase activity in pediatric patients with thalassemia / Tamer Mohamed Abdelkhalek Ashour ; Supervised Khaled Mohamed Salama , Rania Ismail Magdy , Nadia Ibrahim Sewelam
Material type: TextLanguage: English Publication details: Cairo : Tamer Mohamed Abdelkhalek Ashour , 2014Description: 120 P. : facsimiles ; 25cmOther title:- تقييم العامل الخامس لايدن: و الطفرة الجينية للبروثرومبين و المثيلين تيترا هيدروفولات فى الأطفال مرضى انيميا البحر الابيض المتوسط [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.28.M.Sc.2014.Ta.A (Browse shelf(Opens below)) | Not for loan | 01010110064724000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.28.M.Sc.2014.Ta.A (Browse shelf(Opens below)) | 64724.CD | Not for loan | 01020110064724000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics
This study aimed at assessment of factor V Leiden, prothrombin gene mutation and methylenetetrahydrofolate reductase activity in thalassemic patients and its role in thromboembolic manifestation. Study was conducted on 40 thalassemic patients following up at pediatric hematology clinic, New children hospital, Cairo University. Results show that 2 (5%) patients had thromboembolic manifestation and that genotypes of factor V leiden G1691A were 87.5% wild (GG) genotype, 12.5% heterozygote genotype (GA) and 0% homozygous genotype (AA) and A allele frequency was 6.25. Regarding Prothrombin G20210A genotypes were 97.5 wild (GG) genotype, 2.5% heterozygote genotype (GA) and 0% homozygous genotype (AA) and 2A allele3 frequency was 1.25
Issued also as CD
There are no comments on this title.